KIYATEC
KIYATEC, the leader in functional precision oncology with published clinical correlative evidence, is disrupting and informing cancer treatment options by accurately predicting patient tumor-specific response to therapeutics within 7-10 days of specimen receipt. Our mission is to empower physicians with the patient’s tumor-specific treatment response information – beyond what any genomic or diagnostic tool provides today – accurately, precisely and quickly so that patients may benefit from the most effective treatments along their cancer journey.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes